Canterbury DHB

Context

Bacterial Vaginosis

Pathogens

Drug Treatment

Empiric

metronidazole

HMLSchedNZFPMLnoids

PO 400 mg twice a day for 7 days

OR

ornidazole

HMLSchedNZF

PO 500 mg twice a day for 7 days

If non-compliant (less effective than a longer course):

metronidazole

HMLSchedNZFPMLnoids

PO 2000 mg as a single dose

ornidazole

HMLSchedNZF

PO 1500 mg as a single dose

Alternatives such as oral clindamycin and metronidazole vaginal gel may be available. Discuss with Sexual Health/Infectious Diseases/Clinical Microbiology/Obstetrics and Gynaecology.

Information about this Canterbury DHB document (99239):

Document Owner:

Not assigned (see Who's Who)

Last Updated:

May 2019 (Obstetrics and Gynaecology)

Next Review Due:

May 2022

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document.

Topic Code: 99239